Fibrinolytic therapy

DRUG3 trials

Sponsors

All India Institute of Medical Sciences, Denver Health and Hospital Authority, CCRF Inc., Beijing, China

Conditions

CoagulopathyEmpyema, PleuralLeft-sided Prosthetic Heart Valve ThrombosisParapneumonic EffusionST Elevation Myocardial Infarction

Phase 3

Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis

All India Institute of Medical SciencesLeft-sided Prosthetic Heart Valve Thrombosis

Start: 2017-04-30End: 2019-03-31Target: 115Updated: 2017-03-10

Unknown Phase

Treatment of Complicated Parapneumonic Effusion With Fibrinolytic Therapy Versus VATs Decortication

CompletedNCT03583931

Denver Health and Hospital AuthorityCoagulopathy, Empyema, Pleural, Parapneumonic Effusion

Start: 2018-07-26End: 2020-02-02Updated: 2022-01-27

A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Coherence Tomography Guided PCI in STEMI Patients Without Undergoing Primary PCI

CCRF Inc., Beijing, ChinaST Elevation Myocardial Infarction

Start: 2021-07-31End: 2024-03-01Target: 300Updated: 2021-08-09

Related Papers

Neutrophil-Mediated Inflammatory Plasminogen Degradation, Rather Than High Plasminogen-Activator Inhibitor-1, May Underly Failures and Inefficiencies of Intrapleural Fibrinolysis.

2024-05-0611 citations

Effect of Intrapleural Fibrinolytic Therapy vs Surgery for Complicated Pleural Infections

JAMA Network Open2023-04-1216 citations